Moderna: Partnership With IBM to Accelerate mRNA Development

Moderna is a US-based biotechnology company headquartered in Cambridge, Massachusetts, that specializes in the development of mRNA-based therapies and vaccines. Moderna rose to prominence primarily through its COVID-19 vaccine, which is based on mRNA technology and played a central role in the global pandemic response. The company is now working on a broad portfolio that includes not only additional vaccines but also mRNA therapies for cancer, rare diseases, and autoimmune disorders. Moderna utilizes its own digital platform to accelerate development...